StockData
INGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31

Inogen Inc

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$6.55+0.30 (+4.80%)

Close on Oct 19, 2026

Market cap
$177.15M
P/E (TTM)
–
Dividend yield
–

About Inogen

Orthopedic, Prosthetic & Surgical Appliances & Supplies, SIC 3842

Inogen, Inc. is a medical technology company that develops, manufactures, and distributes respiratory health products. Its core offerings include portable oxygen concentrators such as the Inogen One and Inogen Rove systems, designed to deliver supplemental long-term oxygen therapy while allowing patient mobility. The company also distributes stationary oxygen concentrators, CPAP masks for obstructive sleep apnea, and the Simeox airway clearance device for mucus management. Inogen serves patients with chronic respiratory conditions such as chronic obstructive pulmonary disease, cystic fibrosis, and bronchiectasis. The business delivers products directly to patients through direct-to-consumer sales and rentals, while also supplying home medical equipment providers, distributors, resellers, and clinical facilities.

The company distributes its products in the United States and has sold into 70 countries internationally. Inogen operates an engineering and design location in Goleta, California, and maintains an assembly facility in Plano, Texas. Internationally, the firm maintains a customer service center in the Netherlands, conducts device manufacturing in Montpelier, France, and utilizes contract manufacturing services in the Czech Republic.

Summary of the business section of Inogen's latest annual report, written by StockData.

Company profile

Company

Legal name
Inogen Inc
Founded
2001
Headquarters
Beverly, MA
Address
500 Cummings Center, Suite 2800 01915
Phone
(805) 562-0500
Employees
314, Dec 31, 2025
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
Deloitte & Touche LLP, Los Angeles, California, USA

Stock & identifiers

Ticker
INGN
Exchange
Nasdaq
IPO date
Feb 14, 2014
Shares outstanding
27M, Aug 1, 2026
Public float
$190.10M, Jun 30, 2025
Filer category
Accelerated filer<br>Smaller reporting company
SEC CIK
1294133
CUSIP
45780L104
ISIN
US45780L1044
LEI
549300J8WJIVTOJ8IH97
EIN
00-0000000

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Kevin Raymond Merrill SmithCEO and President, Director134,962
Kevin P. SmithEVP, Bus Dev, GC & Sec23,507
Mary E. WrightVP, Chief Accounting Officer20,629
Andrew P. RedingEVP, COO–
Boyer Jennifer M. YiEVP Entrprs Enblmnt, Ch HR Off5,039
Jason Andrew RichardsonEVP, CFO & Treasurer–
Michael J. BourqueEVP, CFO & Treasurer94,557
Gregoire RamadeChief Commercial Officer44,229
Elizabeth MoraDirector107,261
Glenn S. BoehnleinDirector104,966
Mary Kay LadoneDirector104,966
Heather D. RiderDirector118,282
Kevin M. KingDirector104,966
Mira Kirti SahneyDirector67,805
Vafa JamaliDirector43,081

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
Kevin RMSmith
$3.04M$1.87M$1.52M$15$78
FY2024
Kevin RMSmith
$4.16M$5.42M$961.48K$21$78
FY2023
Kevin RMSmith
$1.80M$1.73M$1.08M$12$74
FY2023
Nabil Shabshab
$4.29M-$1.36M$1.08M$12$74
FY2022
Nabil Shabshab
$6.27M$3.24M$2.04M$44$79
FY2021
Nabil Shabshab
$7.04M$5.61M$1.22M$76$103

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we employed 314 people in the United States in our Sales and Marketing organization.”

Corporate history

Events identified from SEC filings